These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16496338)

  • 1. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly.
    Czaja AJ; Carpenter HA
    Hepatology; 2006 Mar; 43(3):532-8. PubMed ID: 16496338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT
    Am J Gastroenterol; 2002 Aug; 97(8):2051-7. PubMed ID: 12190176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4.
    Czaja AJ; Carpenter HA; Moore SB
    Liver Int; 2006 Jun; 26(5):552-8. PubMed ID: 16761999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of HLA DR4 in type 1 autoimmune hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Gastroenterology; 1993 Nov; 105(5):1502-7. PubMed ID: 8224654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.
    Czaja AJ; Souto EO; Bittencourt PL; Cancado EL; Porta G; Goldberg AC; Donaldson PT
    J Hepatol; 2002 Sep; 37(3):302-8. PubMed ID: 12175624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQ associations in type 1 autoimmune hepatitis.
    Czaja AJ; Santrach PJ; Moore SB
    Mayo Clin Proc; 1995 Dec; 70(12):1154-60. PubMed ID: 7490916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis.
    Furumoto Y; Asano T; Sugita T; Abe H; Chuganji Y; Fujiki K; Sakata A; Aizawa Y
    BMC Gastroenterol; 2015 Oct; 15():144. PubMed ID: 26489422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of elderly Chinese patients with autoimmune hepatitis.
    Zhang Y; Sun WL; Jin DL; Jing-Hua D
    Turk J Gastroenterol; 2013; 24(6):489-94. PubMed ID: 24623287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.
    Muratori P; Czaja AJ; Muratori L; Granito A; Guidi M; Ferri S; Volta U; Mantovani W; Pappas G; Cassani F; Lenzi M; Bianchi FB
    Dig Dis Sci; 2007 Jan; 52(1):179-84. PubMed ID: 17160474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor constant beta germline gene polymorphisms and susceptibility to autoimmune hepatitis.
    Manabe K; Hibberd ML; Donaldson PT; Underhill JA; Doherty DG; Demaine AG; Mieli-Vergani G; Eddleston AL; Williams R
    Gastroenterology; 1994 May; 106(5):1321-5. PubMed ID: 7909781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Takaki A; Kobashi H; Sakaguchi K; Shiratori Y
    Intern Med; 2007; 46(24):1945-9. PubMed ID: 18084114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic distinctions between autoimmune hepatitis in Italy and North America.
    Muratori P; Czaja AJ; Muratori L; Pappas G; Maccariello S; Cassani F; Granito A; Ferrari R; Mantovani V; Lenzi M; Bianchi FB
    World J Gastroenterol; 2005 Mar; 11(12):1862-6. PubMed ID: 15793882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
    Montano-Loza A; Czaja AJ; Carpenter HA; Piette A; Murphy D; Shums Z; Burlingame R; Norman GL
    Autoimmunity; 2006 Jun; 39(4):341-8. PubMed ID: 16891223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
    Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients.
    Seki T; Kiyosawa K; Inoko H; Ota M
    Hepatology; 1990 Dec; 12(6):1300-4. PubMed ID: 2175292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis.
    Manabe K; Donaldson PT; Underhill JA; Doherty DG; Mieli-Vergani G; McFarlane IG; Eddleston AL; Williams R
    Hepatology; 1993 Dec; 18(6):1334-7. PubMed ID: 8244257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients.
    Czaja AJ; Carpenter HA; Moore SB
    Dig Dis Sci; 2008 Feb; 53(2):522-8. PubMed ID: 17510796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared genetic risk factors in autoimmune liver disease.
    Czaja AJ; Santrach PJ; Breanndan Moore S
    Dig Dis Sci; 2001 Jan; 46(1):140-7. PubMed ID: 11270778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives.
    Wang P; Su H; Underhill J; Blackmore LJ; Longhi MS; Grammatikopoulos T; Okokon EV; Davies ET; Vergani D; Mieli-Vergani G; Ma Y
    J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):457-62. PubMed ID: 24231645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.